JERRI EDWARDS: Open Payments
NPI 1376043034 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $123 |
| Dexcom, Inc. | 2 | $62 |
| Alkermes, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
Products named: Leqembi, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, REXULTI, ARISTADA, Wegovy, Kerendia, Tirosint.
Industry payments across FL — which companies pay providers there.
